Holen Sie sich die Stockscreener-App
1.99
0.82%
-0.01
Schlusskurs vom Vortag:
$2.00
Offen:
$2.03
24-Stunden-Volumen:
69,940
Relative Volume:
0.09
Marktkapitalisierung:
$4.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.71M
KGV:
-0.1699
EPS:
-11.71
Netto-Cashflow:
$-18.24M
1W Leistung:
+10.82%
1M Leistung:
-38.78%
6M Leistung:
-85.99%
1J Leistung:
-94.86%
1-Tages-Spanne:
$1.95
$2.038
1-Wochen-Bereich:
$1.71
$2.04
52-Wochen-Spanne:
$1.71
$55.00
Genprex Inc Stock (GNPX) Company Profile
Firmenname
Genprex Inc
Sektor
Branche
Telefon
512-537-7997
Adresse
1601 TRINITY STREET, BLDG. B, AUSTIN, TX
Vergleichen Sie GNPX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GNPX
Genprex Inc
|
1.98 | 4.54M | 0 | -22.71M | -18.24M | -11.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.37 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.29 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
814.78 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.34 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Genprex Inc Stock (GNPX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-01-26 | Eingeleitet | National Securities | Buy |
| 2019-04-29 | Eingeleitet | Noble Capital Markets | Outperform |
Genprex Inc Aktie (GNPX) Neueste Nachrichten
Can Genprex Inc. stock beat market expectations this quarterShort Setup & Safe Entry Point Identification - ulpravda.ru
Will Genprex Inc. stock remain a Wall Street favoriteWeekly Risk Report & Weekly Top Performers Watchlists - ulpravda.ru
Can Genprex Inc. stock sustain market leadershipWeekly Trading Summary & AI Based Trade Execution Alerts - ulpravda.ru
How Genprex Inc. stock reacts to inflationary pressuresJuly 2025 PreEarnings & Entry and Exit Point Strategies - ulpravda.ru
Genprex, Inc. Stock (GNPX) Opinions on GPX-002 Diabetes Therapy Data - Quiver Quantitative
Is Genprex Inc. stock a bargain at current levelsSwing Trading Watchlist & Optimize Entry & Exit With Smart Signals - ulpravda.ru
Genprex Advances Diabetes Gene Therapy Program With Preclinical Milestones - Nasdaq
Genprex reports in vivo proof of concept for GPX-002 - BioWorld MedTech
Genprex reports positive data for diabetes gene therapy in animal studies - Investing.com Nigeria
Genprex advances GPX-002 diabetes gene therapy program - TipRanks
Genprex, Inc. Announces Updates on Diabetes Gene Therapy Program - TradingView — Track All Markets
Genprex Provides Clinical Update on Diabetes Gene Therapy Program - PR Newswire
Genprex Advances Diabetes Gene Therapy with Key Milestones Achieved in 2025 - Intellectia AI
Genprex Inc surges 9.44% amid market context - Intellectia AI
Genprex Reports Positive Preclinical Data for Diabetes Gene Therapy in Animal Studies; Shares Rise - marketscreener.com
Genprex Reports Positive Preclinical Data For Diabetes Gene Therapy Candidate GPX-002 - Nasdaq
Genprex reports positive data for diabetes gene therapy in animal studies By Investing.com - Investing.com South Africa
Genprex Reports Positive Preclinical Results for GPX-002 Diabetes Therapy - TipRanks
Genprex Announces Positive Preclinical Data for GPX-002 in Diabetes - TradingView — Track All Markets
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Experimental gene therapy rejuvenates insulin cells in Type 2 diabetes tests - Stock Titan
MSN Money - MSN
Genprex (GNPX) Stock Analysis Report | Financials & Insights - Benzinga Italia
Published on: 2025-12-29 06:37:03 - moha.gov.vn
Genprex reports potential compliance with Nasdaq equity listing rule By Investing.com - Investing.com Canada
Genprex (GNPX) awards 28,500 RSUs to Chief Medical Officer under 2018 plan - Stock Titan
Genprex (GNPX) CEO Ryan Confer reports 45,000 RSUs award - Stock Titan
Genprex (GNPX) grants director 9,000 RSUs after reverse stock split - Stock Titan
Genprex reports potential compliance with Nasdaq equity listing rule - Investing.com
Genprex Updates on Nasdaq Compliance Efforts - TradingView — Track All Markets
Street Watch: Will Genprex Inc stock split attract more investorsMarket Trend Review & Real-Time Stock Movement Alerts - moha.gov.vn
Aug Catalysts: How Genprex Inc. stock reacts to inflationary pressuresQuarterly Profit Review & Verified Chart Pattern Signals - moha.gov.vn
What catalysts could drive Genprex Inc. stock higherJuly 2025 Setups & Long-Term Capital Growth Strategies - Улправда
How Genprex Inc. stock performs in high volatility marketsInflation Watch & Free Real-Time Market Sentiment Alerts - Улправда
Momentum Shift: Why Genprex Inc stock remains on buy listsEarnings Risk Summary & Fast Moving Stock Watchlists - moha.gov.vn
Will Genprex Inc. (2DE0) stock benefit from mergers2025 Performance Recap & Long-Term Investment Growth Plans - Улправда
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Why analysts upgrade Genprex Inc. stock2025 Buyback Activity & Fast Moving Stock Watchlists - DonanımHaber
Will Genprex Inc. stock sustain high P E ratios2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - DonanımHaber
How Genprex Inc. (2DE0) stock reacts to new regulationsQuarterly Portfolio Report & AI Based Trade Execution Alerts - Улправда
Why Genprex Inc. stock is rated strong buyJuly 2025 Final Week & Community Consensus Trade Signals - DonanımHaber
Is Genprex Inc. stock a smart buy before Fed meetingQuarterly Profit Report & Accurate Buy Signal Notifications - DonanımHaber
Genprex Secures U.S. Patent for Reqorsa® Therapy - MSN
Genprex Inc Stock Analysis and ForecastSector-Based Investing & High Yield Market Growth - earlytimes.in
Will Genprex Inc. (2DE0) stock recover faster than industry2025 Analyst Calls & Risk Managed Investment Signals - Newser
Is Genprex Inc. (2DE0) stock undervalued after correctionJuly 2025 PreEarnings & Risk Controlled Daily Trade Plans - Newser
Is Genprex Inc. stock cheap at current valuationWeekly Profit Report & Community Driven Trade Alerts - Newser
Congressman Buys Shares Of Small Cap Lift Truck Company You've Probably Never Heard Of - Benzinga
Can Genprex Inc. (2DE0) stock reach $200 price targetEarnings Growth Summary & Entry and Exit Point Strategies - Newser
Get in on Genprex Inc’s (GNPX) buy-in window today! - setenews.com
Why Genprex Inc. stock remains on buy listsWeekly Profit Summary & Fast Gaining Stock Reports - Newser
Finanzdaten der Genprex Inc-Aktie (GNPX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):